Related Articles
Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro
BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells
Potent anti-metastatic activity of combretastatin-A4
Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo Corrigendum in /10.3892/or.2024.8783
The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses